Tau Biomarkers in Late-onset Psychosis (LOP)
NCT06336382
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Hallucinations or delusions that occur for the first time in older people with no acute medical problems or mood symptoms may be related to impending dementia. This study aims to confirm this hypothesis using novel blood biomarkers and Positron Emission Tomography (PET) imaging tracers, as well as non-invasive testing.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Late Onset Schizophrenia
- Delusional Disorder (Late Onset)
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 65 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Jeremy Koppel
- Last updated on ClinicalTrials.gov
- September 29, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- The Feinstein Institutes for Medical Research · Manhasset, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.